Lithium gamolenate
N/A
Report date: 2025/01/01 20:00:43
Base Information
Drug NameLithium gamolenate
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[20]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesDrexel UniversityEli Lilly And CompanyChina Spinal Cord Injury Network Co Ltd +[8]
Active IndicationsN/A
Inactive Indications +[10]
Other Information
ATC CodeN/A
Related LinksN/A